The case for sex- and gender-specific medicine

JAMA Internal Medicine

Volumn 174, Issue 8, 2014, Pages 1348-1349

  Merz, C Noel Bairey ^a   Regitz Zagrosek, Vera ^b,c  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BUNDLE-BRANCH BLOCK; CARDIAC RESYNCHRONIZATION THERAPY; FEMALE; HEART FAILURE; HUMAN; PROCEDURES;

BUNDLE-BRANCH BLOCK; CARDIAC RESYNCHRONIZATION THERAPY; FEMALE; HEART FAILURE; HUMANS;

EID: 84905841956     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.320     Document Type: Note

References (13)

1. Bairey Merz CN, Mark S, Boyan BD, et al. Proceedings from the scientific symposium: sex differences in cardiovascular disease and implications for therapies. JWomens Health (Larchmt). 2010;19(6): 1059-1072.
2. Oertelt-Prigione S. In: Regitz-Zagrosek V, ed. Sex and Gender Differences in Clinical Medicine. Heidelberg, Germany: Springer; 2012: 3-22.
3. Regitz-Zagrosek V, ed. Sex and Gender Differences in Pharmacology: Handbook of Experimental Pharmacology. Vol 214. Heidelberg, Germany: Springer; 2012: 211-236.
4. Hernandez AF, Fonarow GC, Liang L, et al. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA. 2007;298 (13): 1525-1532.
5. Al-Khatib SM, Hellkamp AS, Hernandez AF, et al; GetWith the Guidelines Steering Committee and Hospitals. Trends in use of implantable cardioverter-defibrillator therapy among patients hospitalized for heart failure: have the previously observed sex and racial disparities changed over time? Circulation. 2012;125(9): 1094-1101.
6. Ghanbari H, Dalloul G, Hasan R, et al. Effectiveness of implantable cardioverterdefibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: ameta-analysis of randomized controlled trials. Arch Intern Med. 2009;169(16): 1500-1506.
7. Regitz-Zagrosek V, Petrov G, Lehmkuhl E, et al. Heart transplantation in women with dilated cardiomyopathy. Transplantation. 2010;89(2): 236-244.
8. Zusterzeel R, Selzman KA, Sanders WE, et al. Cardiac resynchronization therapy in women: US Food and Drug Administrationmeta-analysis of patient-level data [published online June 23, 2014]. JAMA Intern Med. doi: 10.1001/jamainternmed .2014.2717.
9. US Department of Health and Human Services; National Institutes of Health. Monitoring Adherence to the NIH Policy on the Inclusion ofWomen and Minorities as Subjects in Clinical Research: Comprehensive Report: Tracking of Human Subjects Research as Reported in the Fiscal Year 2009 and Fiscal Year 2010. http://orwh.od.nih.gov/resources/policyreports/index.asp. Accessed May 9, 2014.
10. Wizemann TM, Pardue Mary-Lou; Committee on Understanding the Biology of Sex and Gender Differences; Institute of Medicine Board on Health Sciences Policy. Exploring the Biological Contributions to Human Health: Does Sex Matter? Washington, DC: National Academies Press; 2001.
11. Berger JS, Bairey-Merz CN, Redberg RF, Douglas PS; DCRI Think Tank. Improving the quality of care for women with cardiovascular disease: report of a DCRI Think Tank, March 8 to 9, 2007. Am Heart J. 2008;156(5): 816-825, e1.
12. Melloni C, Berger JS,Wang TY, et al. Representation of women in randomized clinical trials of cardiovascular disease prevention. Circ Cardiovasc Qual Outcomes. 2010;3(2): 135-142.
13. Tobi EW, Lumey LH, Talens RP, et al. DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Hum Mol Genet. 2009;18(21): 4046-4053.